Cargando…

Evaluating the feasibility of a pharmacist-guided patient-driven intervention to improve blood pressure control in patients with CKD

BACKGROUND: Self-titration of blood pressure (BP) medications and lifestyle modifications are effective and safe strategies to lower BP. We assessed the feasibility of implementing a pharmacist-guided, patient-driven self-titration protocol and standardized dietary counseling to improve BP in the ch...

Descripción completa

Detalles Bibliográficos
Autores principales: Hopley, Charles, Andrews, Emily, Klem, Patrick, Jonjak, Michelle, Grothe, Ann, Ten Eyck, Patrick, You, Zhiying, Billups, Sarah J., Lyon, Corey, Kennelty, Korey, Dixon, Bradley, Jalal, Diana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6373009/
https://www.ncbi.nlm.nih.gov/pubmed/30805198
http://dx.doi.org/10.1186/s40814-019-0410-0
_version_ 1783394881248428032
author Hopley, Charles
Andrews, Emily
Klem, Patrick
Jonjak, Michelle
Grothe, Ann
Ten Eyck, Patrick
You, Zhiying
Billups, Sarah J.
Lyon, Corey
Kennelty, Korey
Dixon, Bradley
Jalal, Diana
author_facet Hopley, Charles
Andrews, Emily
Klem, Patrick
Jonjak, Michelle
Grothe, Ann
Ten Eyck, Patrick
You, Zhiying
Billups, Sarah J.
Lyon, Corey
Kennelty, Korey
Dixon, Bradley
Jalal, Diana
author_sort Hopley, Charles
collection PubMed
description BACKGROUND: Self-titration of blood pressure (BP) medications and lifestyle modifications are effective and safe strategies to lower BP. We assessed the feasibility of implementing a pharmacist-guided, patient-driven self-titration protocol and standardized dietary counseling to improve BP in the chronic kidney disease (CKD) clinic. METHODS: Adult patients seen in the CKD clinic were identified via registry screening. Inclusion criteria were as follows: a diagnosis of hypertension, average of the last 3 office BP > 150/90 mmHg, and prescribed 3 or fewer BP medications. Patients with severe hypertension were excluded. BP goals were established and patients were referred to the clinical pharmacist who provided them a BP cuff, a BP medication titration plan (based on home BP monitoring), and dietary education. The following outcomes were evaluated: appeal of the program to patients identified by the registry, patient adherence to the protocol and 6-month office BP, and provider attitudes and acceptance of the protocol. RESULTS: Seventeen patients enrolled in the pilot, the majority recruited via clinic schedule screening. Eleven of the 17 patients completed a 6-month office follow-up visit. Three of the 11 patients met their pre-specified office BP goal. There was, however, significant improvement in 6-month office systolic and diastolic BP. Twelve of 17 patients were adherent to entering home BP in EMR. Provider satisfaction with the protocol was high. CONCLUSION: Our preliminary data suggest that patient-driven self-titration of BP medications is feasible and well received by providers. Future studies are needed to validate these findings and to evaluate the safety and efficacy of this approach.
format Online
Article
Text
id pubmed-6373009
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-63730092019-02-25 Evaluating the feasibility of a pharmacist-guided patient-driven intervention to improve blood pressure control in patients with CKD Hopley, Charles Andrews, Emily Klem, Patrick Jonjak, Michelle Grothe, Ann Ten Eyck, Patrick You, Zhiying Billups, Sarah J. Lyon, Corey Kennelty, Korey Dixon, Bradley Jalal, Diana Pilot Feasibility Stud Research BACKGROUND: Self-titration of blood pressure (BP) medications and lifestyle modifications are effective and safe strategies to lower BP. We assessed the feasibility of implementing a pharmacist-guided, patient-driven self-titration protocol and standardized dietary counseling to improve BP in the chronic kidney disease (CKD) clinic. METHODS: Adult patients seen in the CKD clinic were identified via registry screening. Inclusion criteria were as follows: a diagnosis of hypertension, average of the last 3 office BP > 150/90 mmHg, and prescribed 3 or fewer BP medications. Patients with severe hypertension were excluded. BP goals were established and patients were referred to the clinical pharmacist who provided them a BP cuff, a BP medication titration plan (based on home BP monitoring), and dietary education. The following outcomes were evaluated: appeal of the program to patients identified by the registry, patient adherence to the protocol and 6-month office BP, and provider attitudes and acceptance of the protocol. RESULTS: Seventeen patients enrolled in the pilot, the majority recruited via clinic schedule screening. Eleven of the 17 patients completed a 6-month office follow-up visit. Three of the 11 patients met their pre-specified office BP goal. There was, however, significant improvement in 6-month office systolic and diastolic BP. Twelve of 17 patients were adherent to entering home BP in EMR. Provider satisfaction with the protocol was high. CONCLUSION: Our preliminary data suggest that patient-driven self-titration of BP medications is feasible and well received by providers. Future studies are needed to validate these findings and to evaluate the safety and efficacy of this approach. BioMed Central 2019-02-12 /pmc/articles/PMC6373009/ /pubmed/30805198 http://dx.doi.org/10.1186/s40814-019-0410-0 Text en © The Author(s). 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Hopley, Charles
Andrews, Emily
Klem, Patrick
Jonjak, Michelle
Grothe, Ann
Ten Eyck, Patrick
You, Zhiying
Billups, Sarah J.
Lyon, Corey
Kennelty, Korey
Dixon, Bradley
Jalal, Diana
Evaluating the feasibility of a pharmacist-guided patient-driven intervention to improve blood pressure control in patients with CKD
title Evaluating the feasibility of a pharmacist-guided patient-driven intervention to improve blood pressure control in patients with CKD
title_full Evaluating the feasibility of a pharmacist-guided patient-driven intervention to improve blood pressure control in patients with CKD
title_fullStr Evaluating the feasibility of a pharmacist-guided patient-driven intervention to improve blood pressure control in patients with CKD
title_full_unstemmed Evaluating the feasibility of a pharmacist-guided patient-driven intervention to improve blood pressure control in patients with CKD
title_short Evaluating the feasibility of a pharmacist-guided patient-driven intervention to improve blood pressure control in patients with CKD
title_sort evaluating the feasibility of a pharmacist-guided patient-driven intervention to improve blood pressure control in patients with ckd
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6373009/
https://www.ncbi.nlm.nih.gov/pubmed/30805198
http://dx.doi.org/10.1186/s40814-019-0410-0
work_keys_str_mv AT hopleycharles evaluatingthefeasibilityofapharmacistguidedpatientdriveninterventiontoimprovebloodpressurecontrolinpatientswithckd
AT andrewsemily evaluatingthefeasibilityofapharmacistguidedpatientdriveninterventiontoimprovebloodpressurecontrolinpatientswithckd
AT klempatrick evaluatingthefeasibilityofapharmacistguidedpatientdriveninterventiontoimprovebloodpressurecontrolinpatientswithckd
AT jonjakmichelle evaluatingthefeasibilityofapharmacistguidedpatientdriveninterventiontoimprovebloodpressurecontrolinpatientswithckd
AT grotheann evaluatingthefeasibilityofapharmacistguidedpatientdriveninterventiontoimprovebloodpressurecontrolinpatientswithckd
AT teneyckpatrick evaluatingthefeasibilityofapharmacistguidedpatientdriveninterventiontoimprovebloodpressurecontrolinpatientswithckd
AT youzhiying evaluatingthefeasibilityofapharmacistguidedpatientdriveninterventiontoimprovebloodpressurecontrolinpatientswithckd
AT billupssarahj evaluatingthefeasibilityofapharmacistguidedpatientdriveninterventiontoimprovebloodpressurecontrolinpatientswithckd
AT lyoncorey evaluatingthefeasibilityofapharmacistguidedpatientdriveninterventiontoimprovebloodpressurecontrolinpatientswithckd
AT kenneltykorey evaluatingthefeasibilityofapharmacistguidedpatientdriveninterventiontoimprovebloodpressurecontrolinpatientswithckd
AT dixonbradley evaluatingthefeasibilityofapharmacistguidedpatientdriveninterventiontoimprovebloodpressurecontrolinpatientswithckd
AT jalaldiana evaluatingthefeasibilityofapharmacistguidedpatientdriveninterventiontoimprovebloodpressurecontrolinpatientswithckd